Stevanato Group S.p.A (STVN) Equity Income (2020 - 2021)
Stevanato Group S.p.A (STVN) posted quarterly Equity Income of $1.2 million for Q4 2021, up 434.86% year-over-year from $223936.3 in Q4 2020, and up 577.1% quarter-over-quarter from $176893.1 in Q3 2021.
Stevanato Group S.p.A (STVN) Equity Income (2020 - 2021) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Equity Income for 2 consecutive years, with $1.2 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Equity Income rose 434.86% year-over-year to $1.2 million; the TTM figure through Dec 2021 stood at $1.5 million (changed N/A YoY), while the FY2021 annual figure was -$647318.3, down 690.13% from the prior year.
- Equity Income rose to $1.2 million in Q4 2021 per STVN's latest filing, from $176893.1 in the prior quarter.
- Across five years, Equity Income topped out at $1.2 million in Q4 2021 and bottomed at -$471424.9 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 2.23 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 6.10 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 176,893.10 |
| Jun 30, 2021 | 481,708.57 |
| Dec 31, 2020 | -357,686.95 |
| Sep 30, 2020 | 233,615.45 |
| Jun 30, 2020 | -471,424.94 |